Lishman A H, Record C O
J Clin Gastroenterol. 1982 Oct;4(5):421-4. doi: 10.1097/00004836-198210000-00007.
Forty patients with duodenal ulcer were randomly allocated either ranitidine 150 mg twice daily or cimetidine 1 g daily on a single blind basis for 4 weeks initially, with an additional month of treatment if endoscopy showed incomplete healing. The endoscopist was unaware of the patients' treatment. After 8 weeks treatment, the healing rate was 85% for ranitidine and 95% for cimetidine; the difference was not statistically significant. An additional 19 patients who did not fulfill the trial criteria, 11 of whom had not responded to cimetidine, were openly treated with ranitidine 150 mg twice daily. In 16 of the patients, the ulcer had healed at 8 weeks (84%), but in one patient, the ulcer perforated after 6 weeks of therapy. Thus, although overall healing rates with ranitidine and cimetidine are similar, ranitidine may be useful in patients where cimetidine has proved ineffective.
40例十二指肠溃疡患者被随机分为两组,一组每日两次服用150毫克雷尼替丁,另一组每日单次服用1克西咪替丁,最初采用单盲法治疗4周,若内镜检查显示愈合不完全,则再进行1个月的治疗。内镜检查医师不知道患者的治疗情况。治疗8周后,雷尼替丁组的愈合率为85%,西咪替丁组为95%;差异无统计学意义。另外19例不符合试验标准的患者,其中11例对西咪替丁无反应,接受了每日两次150毫克雷尼替丁的开放治疗。16例患者在8周时溃疡已愈合(84%),但有1例患者在治疗6周后溃疡穿孔。因此,虽然雷尼替丁和西咪替丁的总体愈合率相似,但雷尼替丁可能对已证明西咪替丁无效的患者有用。